SCIENION and Pictor Limited Partner to Commercialize High-Throughput SARS-CoV-2 Antibody Testing System to Support Ongoing Fight Against Pandemic

Today SCIENION, a BICO company, announced it has entered into a strategic collaboration with diagnostic biotechnology company Pictor Limited to commercialize a high throughput SARS-CoV-2 antibody testing system. In the collaboration, the two companies will incorporate SCIENION’s CL2 sciREADER system into the PictArray SARS-CoV-2 Serology Test to create the only platform capable of testing both anti-nucleocapsid and anti-spike antibodies in one reaction. This analysis will be key to support the sustained fight against the pandemic by measuring the population’s level of herd immunity through natural infections and vaccinations.

A New Test Could Improve Access to Mental Health Support for Healthcare Professionals Who Are Burned Out From the COVID-19 Pandemic

Research presented today at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo shows that a new test could identify healthcare professionals who are experiencing high levels of work-related stress and anxiety. As COVID-19 cases surge again, this test could play a critical role in helping healthcare professionals on the frontlines of the pandemic to get essential mental health support.

New Noninvasive Tests for Colon and Prostate Cancer Presented at the 2021 AACC Annual Scientific Meeting

Two research teams have developed new noninvasive tests that use either blood or saliva samples to diagnose cases of colorectal cancer or prostate cancer, respectively. Presented today at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo, these tests could facilitate screening efforts for colorectal cancer and allow clinicians to better distinguish early-stage prostate cancer from more benign prostate conditions.

Novel Insights on COVID-19 Vaccines and Virus Evolution, Artificial Intelligence in the Clinic, Miniaturization of Diagnostic Platforms, and Much More to Be Explored at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo

At the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo, laboratory medicine experts will present the cutting-edge research and technology that is revolutionizing clinical testing and patient care.

Most studies of acute kidney injury are flawed due to non-use of standard definitions

In an article published in the American Journal of Kidney Diseases (AJKD), researchers found that among 176 studies on acute kidney injury, the Kidney Disease Improving Global Outcomes (KDIGO) definitions of kidney injury were inconsistently applied and 80% of studies…

Risk score with 6 routinely available lab tests accurately predicts kidney failure

Researchers developed a new risk equation, based on six routinely available patient parameters, that yielded improved performance in estimating the risk of a chronic kidney disease (CKD) patient to progress to end-stage kidney disease (ESKD) requiring kidney replacement therapy (KRT).…

Artificial intelligence provides faster diagnosis for debilitating blistering disease

Scientists at the University of Groningen have trained an Artificial Intelligence system to recognize a specific pattern in skin biopsies of patients with the blistering disease epidermolysis bullosa acquisita. The pattern is characteristic of a specific variant of the disease…

Understanding frailty will lead to better care for older adults

Frailty is a better predictor than factors such as age when determining how older adults fare one year after receiving critical care. A team led by researchers from the University of Waterloo analyzed data from more than 24,000 community-dwelling older…

SARS-CoV-2 encoded miRNA is a biomarker for stratification of severe patients

In a retrospective, multi-centre cohort study conducted by researchers from Nanjing University, Huazhong University of Science and Technology, Jinling Hospital and the Second Hospital of Nanjing, a microRNA-like small RNA encoded by SARS-CoV-2 was identified in the serum of COVID-19…

Hi-tech lab to boost COVID-19 diagnostic capability, prepare for future pandemics

Singapore, 1 July 2021 – Nanyang Technological University, Singapore (NTU Singapore) and Pathnova Laboratories, a medical diagnostic company backed by Temasek Life Sciences Accelerator and headquartered in Temasek Life Sciences Laboratory, is contributing to Singapore’s COVID-19 diagnostic capability through its…

‘Genomics of Rare Diseases. Understanding Disease Genetics Using Genomic Approaches’

In 2018, Dr. Claudia Gonzaga-Jáuregui, who years before had completed her doctorate studies in Dr. James R. Lupski’s lab at Baylor College of Medicine, received an email from an editor at Elsevier’s Academic Press with a proposal that immediately caught…

State of the art and future directions in the clinical application of HR-pQCT in adults

A new international guidance on the clinical application of high-resolution peripheral computed tomography (HR-pQCT) offers an important overview of current clinical applications in adults and direction on the interpretation of results

Foresight diagnostics to show vision of the new standard of lymphoma MRD detection at ICML

AURORA, COLORADO, June 16, 2021 — Foresight Diagnostics, the emerging leader in blood-based lymphoma disease monitoring, announced today that clinical performance of its minimal residual disease (MRD) detection platform in diffuse large B-cell lymphoma (DLBCL) will be presented at the…